CaMKIIδC Drives Early Adaptive Ca


Journal

Circulation research
ISSN: 1524-4571
Titre abrégé: Circ Res
Pays: United States
ID NLM: 0047103

Informations de publication

Date de publication:
09 10 2020
Historique:
pubmed: 22 8 2020
medline: 25 5 2021
entrez: 22 8 2020
Statut: ppublish

Résumé

CaMKII (Ca To measure time- and location-dependent activation of CaMKIIδC signaling in adult ventricular cardiomyocytes, during transaortic constriction (TAC) and in CaMKIIδC transgenic mice. We used human tissue from nonfailing and HF hearts, 4 mouse lines: wild-type, KO (CaMKIIδ-knockout), CaMKIIδC transgenic in wild-type (TG), or KO background, and wild-type mice exposed to TAC. Confocal imaging and biochemistry revealed disproportional CaMKIIδC activation and accumulation in nuclear and perinuclear versus cytosolic regions at 5 days post-TAC. This CaMKIIδ activation caused a compensatory increase in sarcoplasmic reticulum Ca We conclude that in early TAC perinuclear CaMKIIδC activation promotes adaptive increases in myocyte Ca

Identifiants

pubmed: 32821022
doi: 10.1161/CIRCRESAHA.120.316947
pmc: PMC7547876
mid: NIHMS1623696
doi:

Substances chimiques

Calcium-Binding Proteins 0
phospholamban 0
Calcium-Calmodulin-Dependent Protein Kinase Type 2 EC 2.7.11.17
Hdac5 protein, mouse EC 3.5.1.98
Histone Deacetylases EC 3.5.1.98
Sarcoplasmic Reticulum Calcium-Transporting ATPases EC 3.6.3.8
Atp2a2 protein, mouse EC 7.2.2.10
Calcium SY7Q814VUP

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1159-1178

Subventions

Organisme : NHLBI NIH HHS
ID : K99 HL138160
Pays : United States
Organisme : NHLBI NIH HHS
ID : R00 HL138160
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL092097
Pays : United States
Organisme : NHLBI NIH HHS
ID : P01 HL141084
Pays : United States
Organisme : Austrian Science Fund FWF
ID : I 3301
Pays : Austria
Organisme : NHLBI NIH HHS
ID : R37 HL028143
Pays : United States
Organisme : NHLBI NIH HHS
ID : R37 HL030077
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL145459
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL142282
Pays : United States

Références

J Mol Cell Cardiol. 2020 Jan;138:212-221
pubmed: 31836540
Circ Arrhythm Electrophysiol. 2018 Feb;11(2):e005852
pubmed: 29437761
Biochem Biophys Res Commun. 2016 Apr 8;472(3):523-30
pubmed: 26966065
J Mol Cell Cardiol. 2018 Dec;125:18-28
pubmed: 30321537
Biophys J. 2011 May 18;100(10):2356-66
pubmed: 21575569
Circ Res. 1999 Apr 2;84(6):713-21
pubmed: 10189359
Front Pharmacol. 2014 Feb 11;5:15
pubmed: 24575042
Circulation. 2010 Sep 7;122(10):993-1003
pubmed: 20733099
J Cell Sci. 2008 Jan 15;121(Pt 2):186-95
pubmed: 18089647
Circ Res. 2005 Dec 9;97(12):1314-22
pubmed: 16269653
Circulation. 2018 Nov 27;138(22):2530-2544
pubmed: 30571348
Channels (Austin). 2015;9(3):129-38
pubmed: 25891132
J Mol Cell Cardiol. 2017 Feb;103:48-55
pubmed: 28077321
J Am Coll Cardiol. 2014 Apr 22;63(15):1569-79
pubmed: 24315909
Circulation. 2014 Jul 15;130(3):244-55
pubmed: 24928680
Br J Pharmacol. 2013 Jan;168(2):296-317
pubmed: 22946456
J Biol Chem. 2013 Jan 4;288(1):192-204
pubmed: 23161540
J Biol Chem. 2009 Sep 11;284(37):24857-68
pubmed: 19602725
J Mol Cell Cardiol. 2016 Nov;100:1-8
pubmed: 27642167
Circ Res. 2008 Mar 28;102(6):695-702
pubmed: 18218981
J Physiol. 2007 Oct 15;584(Pt 2):601-11
pubmed: 17761776
Annu Rev Physiol. 2008;70:23-49
pubmed: 17988210
J Clin Invest. 2011 Jun;121(6):2301-12
pubmed: 21537080
Circ Res. 2006 Jan 6;98(1):15-24
pubmed: 16397154
Circ Res. 2011 Sep 16;109(7):729-38
pubmed: 21835909
Circ Res. 2003 May 2;92(8):904-11
pubmed: 12676813
Cell Signal. 2017 Aug;36:240-254
pubmed: 28412414
Heart Fail Rev. 2009 Dec;14(4):213-24
pubmed: 19434491
Circ Res. 2010 Oct 29;107(9):1150-61
pubmed: 20814023
Cell Signal. 2019 Nov;63:109357
pubmed: 31299211
Methods Mol Biol. 2015;1234:135-47
pubmed: 25304354
J Pathol. 2015 Mar;235(4):606-18
pubmed: 25421395
J Mol Cell Cardiol. 2011 Oct;51(4):468-73
pubmed: 21276796
Sci Rep. 2014 May 12;4:4923
pubmed: 24815916
J Cell Biol. 2011 Oct 31;195(3):403-15
pubmed: 22042619
Circ Res. 2012 Aug 3;111(4):493-504
pubmed: 22859671
Nat Cell Biol. 2019 Sep;21(9):1152-1163
pubmed: 31481791
J Biol Chem. 2007 Nov 30;282(48):35078-87
pubmed: 17923476
Sci Signal. 2014 Mar 18;7(317):ra27
pubmed: 24643800
Circ Arrhythm Electrophysiol. 2014 Dec;7(6):1205-13
pubmed: 25236710
Circ Res. 2011 Dec 9;109(12):1354-62
pubmed: 21998325
Eur J Heart Fail. 2014 Dec;16(12):1292-300
pubmed: 25201344
Circ Res. 2003 May 2;92(8):912-9
pubmed: 12676814
J Clin Invest. 2006 Mar;116(3):675-82
pubmed: 16511602
J Clin Invest. 2009 May;119(5):1230-40
pubmed: 19381018
J Cell Mol Med. 2020 Aug;24(15):8732-8743
pubmed: 32573098
Circ Res. 1999 Nov 26;85(11):1009-19
pubmed: 10571531
Cardiovasc Res. 2010 Jul 1;87(1):50-9
pubmed: 20080988
Nature. 2013 Oct 17;502(7471):372-6
pubmed: 24077098
J Mol Cell Cardiol. 2007 Mar;42(3):590-9
pubmed: 17239900

Auteurs

Senka Ljubojevic-Holzer (S)

Department of Cardiology (S.L.-H., N.D., J.V., M.A., I.M., M.S., S.R., M.W., D.v.L., S. Sedej), Medical University of Graz, Austria.
Department of Pharmacology, University of California, Davis, CA (S.L.-H., A.W.H., S.M., B.M.W., J.B., D.M.B.).
BioTechMed Graz, Austria (S.L.-H., J.V., S. Sedej).

Anthony W Herren (AW)

Department of Pharmacology, University of California, Davis, CA (S.L.-H., A.W.H., S.M., B.M.W., J.B., D.M.B.).

Natasa Djalinac (N)

Department of Cardiology (S.L.-H., N.D., J.V., M.A., I.M., M.S., S.R., M.W., D.v.L., S. Sedej), Medical University of Graz, Austria.

Julia Voglhuber (J)

Department of Cardiology (S.L.-H., N.D., J.V., M.A., I.M., M.S., S.R., M.W., D.v.L., S. Sedej), Medical University of Graz, Austria.
BioTechMed Graz, Austria (S.L.-H., J.V., S. Sedej).

Stefano Morotti (S)

Department of Pharmacology, University of California, Davis, CA (S.L.-H., A.W.H., S.M., B.M.W., J.B., D.M.B.).

Michael Holzer (M)

Otto-Loewi Research Centre, Division of Pharmacology (M.H.), Medical University of Graz, Austria.

Brent M Wood (BM)

Department of Pharmacology, University of California, Davis, CA (S.L.-H., A.W.H., S.M., B.M.W., J.B., D.M.B.).

Mahmoud Abdellatif (M)

Department of Cardiology (S.L.-H., N.D., J.V., M.A., I.M., M.S., S.R., M.W., D.v.L., S. Sedej), Medical University of Graz, Austria.

Ingrid Matzer (I)

Department of Cardiology (S.L.-H., N.D., J.V., M.A., I.M., M.S., S.R., M.W., D.v.L., S. Sedej), Medical University of Graz, Austria.

Michael Sacherer (M)

Department of Cardiology (S.L.-H., N.D., J.V., M.A., I.M., M.S., S.R., M.W., D.v.L., S. Sedej), Medical University of Graz, Austria.

Snjezana Radulovic (S)

Department of Cardiology (S.L.-H., N.D., J.V., M.A., I.M., M.S., S.R., M.W., D.v.L., S. Sedej), Medical University of Graz, Austria.

Markus Wallner (M)

Department of Cardiology (S.L.-H., N.D., J.V., M.A., I.M., M.S., S.R., M.W., D.v.L., S. Sedej), Medical University of Graz, Austria.

Milan Ivanov (M)

Institute for Medical Research, University of Belgrade, Serbia (M.I.).

Stefan Wagner (S)

Klinik und Poliklinik für Innere Medizin II, Universitätsklinikum Regensburg, Germany (S.W., S. Sossalla).

Samuel Sossalla (S)

Klinik für Kardiologie und Pneumologie, Georg-August-Universität Göttingen, Germany (S. Sossalla).
Klinik und Poliklinik für Innere Medizin II, Universitätsklinikum Regensburg, Germany (S.W., S. Sossalla).

Dirk von Lewinski (D)

Department of Cardiology (S.L.-H., N.D., J.V., M.A., I.M., M.S., S.R., M.W., D.v.L., S. Sedej), Medical University of Graz, Austria.

Burkert Pieske (B)

Department of Internal Medicine and Cardiology, Charité University Medicine Berlin, Germany (B.P.).

Joan Heller Brown (JH)

Department of Pharmacology, University of California San Diego, La Jolla (J.H.B.).

Simon Sedej (S)

Department of Cardiology (S.L.-H., N.D., J.V., M.A., I.M., M.S., S.R., M.W., D.v.L., S. Sedej), Medical University of Graz, Austria.
BioTechMed Graz, Austria (S.L.-H., J.V., S. Sedej).
Faculty of Medicine, Institute of Physiology, University of Maribor, Slovenia (S. Sedej).

Julie Bossuyt (J)

Department of Pharmacology, University of California, Davis, CA (S.L.-H., A.W.H., S.M., B.M.W., J.B., D.M.B.).

Donald M Bers (DM)

Department of Pharmacology, University of California, Davis, CA (S.L.-H., A.W.H., S.M., B.M.W., J.B., D.M.B.).

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH